Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis

Journal of Clinical Apheresis

Volumn 13, Issue 4, 1998, Pages 163-166

  Wallace, Daniel J ^a,c   Goldfinger, Dennis ^a   Pepkowitz, Samuel H ^a   Fichman, Marshal ^a   Metzger, Allan L ^a   Schroeder, Johann O ^b   Euler, Hans H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c NONE   (United States)

Author keywords

Cyclophosphamide therapy; Proliferative lupus nephritis; Pulse synchronization apheresis

Indexed keywords

COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; FEMALE; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PLASMAPHERESIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD COMPONENT REMOVAL; CELL DIVISION; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS;

EID: 0032432829     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1998)13:4<163::AID-JCA4>3.0.CO;2-1     Document Type: Article

References (17)

1. Wallace DJ, Hahn BH, Klippel JH: Lupus nephritis. In Wallace DJ, Hahn BH (eds): Dubois' Lupus erythematous, 5th edition. Baltimore: Williams & Wilkens, 1997, pp 1053-1066.
2. Gladman DD, Urowitz MB: Prognostic studies and mortality in systemic lupus erythematosus. In Wallace DJ, Hahn BH (eds): Dubois' Lupus Erythematosus, 5th edition. Baltimore: Williams & Wilkens, 1997, pp 1213-1228.
3. Jones JV, Cumming RH, Bucknall RC, Asplin CM, Fraser ID, Bothamley J, Davis P, Hamblin TJ: Plasmapheresis in the management of systemic lupus erythematosus? Lancet 1:709-711, 1976.
4. Wallace DJ: Plasmapheresis in lupus (editorial). Lupus 2:141-143, 1993.
5. Lewis EJ, Hunsicker LG, Lan S-P, Rhode RD, Lachin RD: A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373-1379, 1992.
6. Wallace DJ, Goldfinger D, Savage G, Nichols S, Goodman D, Fichman M, Stewart M, Klinenberg JR: Prediction value of clinical, laboratory, pathologic and treatment variables in steroid/immunosuppressive resistant lupus nephritis. J Clin Apheresis 4: 30-34, 1988.
7. Euler HH, Schroeder JO, Loffler H: Antibody depletion and cytotoxic drug therapy in systemic lupus erythematosus. Transfus Sci 13:167-184, 1992.
8. Schroeder JO, Euler HE, Loffler H: Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Med 107:344-346, 1987.
9. Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NF. Schaller JG, Talal N, Winchester RJ: Special article: the 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982.
10. Liang MM, Socher SA, Roberts WN, Esdaile JM: Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 31:817-825, 1992.
11. Wallace DJ, Podell TE, Weiner J, Cox M, Klinenberg JR, Forouzesh S, Dubois EL: Lupus nephritis: experience with 230 patients in a private practice from 1950-1980. Am J Med 72:209-220, 1982.
12. Neumann K, Wallace DJ, Azen C, Nessim S, Fichman M, Metzger AL, Klinenberg JR: Lupus in the 1980s: III. Influence of clinical variables, biopsy and treatment on the outcome of 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 25:475-485, 1995.
13. Schroeder JO, Schwab U, Zeuner R, Fastenrath S, Euler HH: Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. Preliminary results of the LPSG-Trial. Arthritis Rheum 40:S325, 1997.
14. Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741-745, 1992.
15. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37:1784-1794, 1994.
16. Schroeder JO, Euler H: Recognition and management systemic lupus erythematosus. Drugs 54:422-434, 1997.
17. Jones JV: Plasmapheresis in systemic lupus erythematosus. Clin Rheum Dis 8:243-260, 1982.